Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dPEP-KE: Doxycycline PEP for STI Prevention in Kenyan Women
NCT04050540Phase 4Completed
- Sponsor
- University of Washington
- Start
- Feb 2020
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doxycycline in Chlamydia trachomatis infection, gonorrhea, syphilis, sponsored by University of Washington. Started Feb 2020; status: completed.
02
Drugs
doxycycline
03
Conditions
Chlamydia trachomatis infectiongonorrheasyphilis
Beyond the preview
Go deeper on NCT04050540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04050540.